Access 2.8M+ Filings Sign Up Free
Aptahem AB Logo

Aptahem AB | APTA - Profile, Filings, Stock Info & Investor Relations Data

Aptahem AB | APTA
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
N/A
Aptahem AB (APTA)

Company Profile

Website
Investor Relations

About Aptahem AB

Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue. A large part of the research is carried out in collaboration with partners within the industry. The company was founded in 2014 and is based in Malmö.

Headquarters

Norra Vallgatan 58
211 22, Malmö
Sweden

Aptahem AB (APTA)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Aptahem AB (APTA)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Aptahem AB (APTA)
Stock & Investor Information

ISINs

SE0022447173
SE0023135306
SE0023135314

LEI

549300IVD1BY4CJMSO40

Stock Exchange Listings

Spotlight Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology